Introducing Oncology Biomarker Testing Feature | PrescriberPoint

Shannon E. Epling MSc, Pharmaceutical Sciences Date: 07/19/2023

With the introduction of the Biomarker Testing feature, we aim to revolutionize the way oncology healthcare professionals access and leverage critical drug information.

This feature is specifically designed to address the needs of oncology practitioners, providing them with comprehensive and reliable data to support their treatment decisions.

The Importance of Comprehensive Information:

Oncology healthcare professionals face the challenge of staying updated with the latest advancements in oncology therapies, including the introduction of targeted therapies and immunotherapies. These treatments often rely on specific biomarkers that help identify patients who are most likely to respond to a particular therapy. Therefore, having access to a comprehensive database that provides information on clinical trials, biomarker names, therapy selection, and testing methodologies is crucial for making well-informed treatment decisions and aligning with the latest research and clinical guidelines.

Biomarker Name and Therapy Selection:

The proposed "Biomarker Testing" section on PrescriberPoint will offer a detailed list of biomarker names associated with indications. Biomarkers play a critical role in identifying patients who are likely to benefit from a specific treatment approach. By having access to this information, healthcare professionals can effectively determine the appropriate therapy selection for their patients, leading to improved treatment outcomes and minimizing unnecessary side effects.

Testing Methodology:

Another key aspect of the new feature is providing detailed information on the testing methodology associated with obtaining the genetic profile for that cancer type. Different drugs may require specific testing approaches to evaluate patient eligibility, monitor treatment response, and detect potential adverse reactions. By offering comprehensive insights into the testing methodologies, PrescriberPoint empowers healthcare professionals to stay up-to-date with the latest advancements in oncology testing, ensuring optimal patient care.

Benefits of the "Biomarker Testing" Section

The inclusion of a dedicated section on PrescriberPoint offers several significant benefits to oncology healthcare professionals:

  • Enhanced Treatment Decision-Making: By having access to essential information about clinical trials, biomarker names, therapy selection, and testing methodologies, healthcare professionals can make more informed treatment decisions tailored to individual patients. This personalized approach increases the likelihood of successful outcomes.
  • Stay Updated with Advancements: The field of oncology is rapidly evolving, with new therapies and testing methodologies constantly emerging. With the additional section, healthcare professionals can stay updated with the latest advancements and integrate them into their clinical practice.
  • Time Efficiency: Having a comprehensive resource like PrescriberPoint eliminates the need to search multiple platforms or consult various sources for testing-related information. This saves valuable time for healthcare professionals, enabling them to focus more on patient care.
  • Enhanced User Experience: PrescriberPoint's user-centric design places user experience at the forefront. The "Biomarker Testing" feature seamlessly integrates into the existing drug pages, ensuring a cohesive and intuitive browsing experience. Healthcare professionals can now navigate through the platform effortlessly, accessing critical drug information with ease.
  • Reliability: All testing requirements are curated from the most recent NCCN guidelines for each cancer type. As many of you may already know, these documents are oftentimes extensive and difficult to locate necessary information. PrescriberPoint’s content team has extracted this information from the NCCN documents and provided the details in a more consumable format.

At PrescriberPoint, we understand the importance of data accuracy and reliability. The "Biomarker Testing" feature undergoes rigorous quality control measures, ensuring that the entered data is thoroughly validated and adheres to industry standards. We are committed to maintaining the highest level of data integrity, providing healthcare professionals with trustworthy information they can rely on.

We are excited to launch this feature as part of our ongoing commitment to empowering oncology healthcare professionals. The addition of a dedicated "Biomarker Testing" section on PrescriberPoint addresses the need for comprehensive and reliable information on the testing aspects of oncology drugs. By providing essential details such as biomarker names, therapy selection, and testing methodologies, this section empowers oncology healthcare professionals to make well-informed treatment decisions and stay updated with the latest advancements in oncology therapies. As a result, patient outcomes can be improved, and the field of oncology can continue to progress towards more personalized and effective care.

To experience the power of this new feature, log in to your PrescriberPoint account today. If you don't have an account yet, sign up now and join the community of healthcare professionals benefiting from our innovative platform.

Stay tuned for further updates and enhancements as we continue to evolve and revolutionize the way you access and utilize drug information on PrescriberPoint.

At PrescriberPoint, we're dedicated to empowering healthcare professionals and transforming patient care. Join us on this exciting journey!


Get the latest insights delivered to your inbox

Explore our blog

Need Support? Get in touch